• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口服全细胞灭活霍乱疫苗在 Sprague Dawley 大鼠中的药理学和毒理学。

Pharmacology and toxicology of an oral tablet whole cells inactivated cholera vaccine in Sprague Dawley rats.

机构信息

Finlay Institute, Center for Research-Production of Vaccines, 27th Ave. No. 19805, La Lisa, Ciudad de la Habana 11600, Cuba.

出版信息

Vaccine. 2011 Apr 27;29(19):3596-9. doi: 10.1016/j.vaccine.2011.02.074. Epub 2011 Mar 6.

DOI:10.1016/j.vaccine.2011.02.074
PMID:21385634
Abstract

Here we further investigate the pharmacological and toxicological properties of a cholera vaccine based on inactivated whole cells presented in either enteric coated (COA) or uncoated (U/C) tablet formulation from Vibrio cholerae C7258 strain. Tablets were dispersed in 2mL drinking water and administered orally to Sprague Dawley rats distributed in five groups (I COA7, II U/C7 immunized at 0, 7, 69days and III COA14, IV U/C14 immunized at 0, 14, 69days and V control group). Serum vibriocidal antibody response was measured after the administration of two doses with an interval of 7-14days. To further investigate the toxicological aspects a third dose was applied 10 weeks after the initial one. Animals were observed daily and water and food consumption was measured every other day. Periodic blood extractions were performed for hematology, biochemistry, and the titer of serum vibriocidal antibodies was determined. Anatomopathological analysis was performed at days 3 or 14 after the third dose. Results from clinical observations, as well as from water and food consumption and body weigh indicated no toxicity of the vaccine product. Meanwhile, no biological differences were found among different groups in hematological, hemo-chemistry, and anatomopathological studies. Moreover, enteric coated and uncoated tablets against human cholera were found to induce an immune response in rats.

摘要

在这里,我们进一步研究了基于灭活全细胞的霍乱疫苗的药理学和毒理学特性,该疫苗来自霍乱弧菌 C7258 株,以肠溶包衣(COA)或未包衣(U/C)片剂的形式呈现。将片剂分散在 2mL 饮用水中,口服给予分布在五个组(I COA7、II U/C7 在 0、7、69 天免疫,III COA14、IV U/C14 在 0、14、69 天免疫和 V 对照组)的 Sprague Dawley 大鼠。在两次给药之间间隔 7-14 天后,测量血清杀菌抗体反应。为了进一步研究毒理学方面,在初次给药后 10 周应用了第三剂。每天观察动物,每隔一天测量水和食物的消耗。定期进行血液提取,用于血液学、生物化学以及血清杀菌抗体滴度的测定。在第三次给药后第 3 天或第 14 天进行解剖病理学分析。临床观察、水和食物消耗以及体重的结果表明疫苗产品无毒。同时,在血液学、血液化学和解剖病理学研究中,不同组之间没有发现生物学差异。此外,针对人类霍乱的肠溶包衣和未包衣片剂被发现能够在大鼠中诱导免疫反应。

相似文献

1
Pharmacology and toxicology of an oral tablet whole cells inactivated cholera vaccine in Sprague Dawley rats.口服全细胞灭活霍乱疫苗在 Sprague Dawley 大鼠中的药理学和毒理学。
Vaccine. 2011 Apr 27;29(19):3596-9. doi: 10.1016/j.vaccine.2011.02.074. Epub 2011 Mar 6.
2
Formulation in tablets of a cholera whole cells inactivated vaccine candidate.霍乱全细胞灭活候选疫苗的片剂剂型
Vaccine. 2006 Apr 12;24(16):3381-7. doi: 10.1016/j.vaccine.2005.12.064. Epub 2006 Jan 19.
3
Evaluation of enteric-coated tablets as a whole cell inactivated vaccine candidate against Vibrio cholerae.评估肠溶片剂作为霍乱弧菌全细胞灭活疫苗候选物。
Travel Med Infect Dis. 2013 Mar-Apr;11(2):103-9. doi: 10.1016/j.tmaid.2012.10.006. Epub 2013 Mar 13.
4
Repeated dose toxicity study of a live attenuated oral cholera vaccine in Sprague Dawley rats.Sprague Dawley 大鼠口服减毒活霍乱疫苗重复剂量毒性研究。
Arch Med Res. 2009 Oct;40(7):527-35. doi: 10.1016/j.arcmed.2009.09.003.
5
Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.口服灭活全细胞重组B亚单位霍乱疫苗在哥伦比亚巴兰基亚的安全性和免疫原性。
Bull Pan Am Health Organ. 1995 Dec;29(4):312-21.
6
Stimulation of mucosal immune response following oral administration of enterotoxigenic Escherichia coli fimbriae (CFA/I) entrapped in liposomes in conjunction with inactivated whole-cell Vibrio cholerae vaccine.口服包裹在脂质体中的产肠毒素大肠杆菌菌毛(CFA/I)并联合灭活全细胞霍乱弧菌疫苗后对黏膜免疫反应的刺激作用。
Roum Arch Microbiol Immunol. 2001 Jan-Mar;60(1):27-54.
7
Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: a randomized, placebo-controlled trial.印度加尔各答成人和儿童接种一剂及两剂重新配方的二价、灭活、全细胞口服霍乱疫苗后的免疫反应:一项随机、安慰剂对照试验。
Vaccine. 2009 Nov 16;27(49):6887-93. doi: 10.1016/j.vaccine.2009.09.008. Epub 2009 Sep 15.
8
Investigations into the safety and immunogenicity of a killed oral cholera vaccine developed in Viet Nam.对越南研发的一种口服霍乱灭活疫苗的安全性和免疫原性的调查。
Bull World Health Organ. 2002;80(1):2-8.
9
Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.在孟加拉国受试者口服灭活二价霍乱弧菌O1/O139全细胞霍乱疫苗免疫后,在其黏膜表面检测到强大的肠道相关疫苗特异性抗体分泌细胞反应:与其他黏膜和全身反应的比较。
Vaccine. 2009 Feb 25;27(9):1386-92. doi: 10.1016/j.vaccine.2008.12.041. Epub 2009 Jan 13.
10
Immunogenicity and protective efficacy of Vibrio cholerae outer membrane vesicles in rabbit model.霍乱弧菌外膜囊泡在兔模型中的免疫原性和保护效力
FEMS Immunol Med Microbiol. 2010 Oct;60(1):18-27. doi: 10.1111/j.1574-695X.2010.00692.x.

引用本文的文献

1
Challenges and Considerations in Selecting Animal Models for Evaluating a Live, Cold-Chain-Free, Dual-Use Vaccine (MyChol) for Diarrhoeal Diseases: A Comprehensive Review.选择动物模型以评估用于腹泻疾病的即用型、无冷链、两用疫苗(MyChol)的挑战与考量:全面综述
Malays J Med Sci. 2024 Oct;31(5):41-55. doi: 10.21315/mjms2024.31.5.4. Epub 2024 Oct 8.
2
Pre-Clinical Safety and Immunogenicity Study of a Coronavirus Protein-Based Subunit Vaccine for COVID-19.一种用于COVID-19的基于冠状病毒蛋白的亚单位疫苗的临床前安全性和免疫原性研究
Vaccines (Basel). 2023 Nov 28;11(12):1771. doi: 10.3390/vaccines11121771.
3
Safety and immunogenicity of the first Kazakh inactivated vaccine for COVID-19.
首支哈萨克斯坦国产新冠病毒灭活疫苗的安全性和免疫原性。
Hum Vaccin Immunother. 2022 Nov 30;18(5):2087412. doi: 10.1080/21645515.2022.2087412. Epub 2022 Aug 12.
4
Repeat-dose and local tolerance toxicity of SARS-CoV-2 FINLAY-FR-02 vaccine candidate in Sprague Dawley rats.SARS-CoV-2候选疫苗FINLAY-FR-02在Sprague Dawley大鼠中的重复给药及局部耐受性毒性
Toxicology. 2022 Apr 15;471:153161. doi: 10.1016/j.tox.2022.153161. Epub 2022 Mar 29.
5
Repeat-Dose Toxicity Study Using the AFPL1-Conjugate Nicotine Vaccine in Male Sprague Dawley Rats.使用AFPL1缀合尼古丁疫苗对雄性斯普拉格-道利大鼠进行重复给药毒性研究。
Pharmaceutics. 2019 Nov 23;11(12):626. doi: 10.3390/pharmaceutics11120626.
6
Animal Models of Type III Secretion System-Mediated Pathogenesis.III型分泌系统介导的发病机制的动物模型
Pathogens. 2019 Nov 22;8(4):257. doi: 10.3390/pathogens8040257.
7
Assessing the immunogenicity and toxicity of the AFPL1-conjugate nicotine vaccine using heterologous and homologous vaccination routes.评估 AFPL1 缀合尼古丁疫苗的免疫原性和毒性:使用异源和同源接种途径。
PLoS One. 2019 Aug 23;14(8):e0221708. doi: 10.1371/journal.pone.0221708. eCollection 2019.
8
Toxicological Assessment of the Cochleate Derived from Neisseria meningitidis Proteoliposome in Sprague Dawley Rats.脑膜炎奈瑟菌蛋白脂质体衍生的螺旋体在Sprague Dawley大鼠中的毒理学评估。
N Am J Med Sci. 2012 Mar;4(3):135-40. doi: 10.4103/1947-2714.93888.